BIGBEAR PHARMACEUTICALS
There is no trivial matter in pharmaceuticals; quality is the lifeline.
Ivosidenib can reduce the production of the oncogenic metabolite 2-HG by selectively targeting and inhibiting the activity of the mutant IDH1 enzyme.
WhatsApp
Copyright2024@ BIGBEAR All right reserved BIGBEAR
Order on WhatsApp